Article ID Journal Published Year Pages File Type
9184311 Seminars in Thoracic and Cardiovascular Surgery 2005 6 Pages PDF
Abstract
The stage-specific selection of therapy is the standard for patients with non-small cell lung cancer. Investigation of the molecular biology of lung cancer has provided pathways and targets that may be used to improve the efficacy of therapy and improve the survival for patients with lung cancer.
Related Topics
Health Sciences Medicine and Dentistry Cardiology and Cardiovascular Medicine
Authors
,